secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0000950170-23-028678
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed annual meeting adjourned; potential Nasdaq delisting risk from quorum issue
--------------------------------------------------------------------------------

- 2023 annual general meeting on June 15 failed due to lack of 33 1/3% quorum; reconvened for June 21 at 10 a.m. ET.
- Articles allow meeting to proceed with whatever persons present if quorum not met within 30 minutes of reconvened meeting.
- Nasdaq may issue non-compliance letter if less than 33 1/3% present; company has 45 days to submit plan, possible 180-day extension.
- Potential delisting would negatively impact liquidity and market price; company believes it can regain compliance but no assurance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000095017023028678/0000950170-23-028678-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000095017023028678/mnmd-20230616.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-028678

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer